131 related articles for article (PubMed ID: 37435892)
1. Malaria Biomimetic for Tumor Targeted Drug Delivery.
Pihl J; Clausen TM; Zhou J; Krishnan N; Ørum-Madsen MS; Gustavsson T; Dagil R; Daugaard M; Choudhary S; Foged C; Esko JD; Zhang L; Fang RH; Salanti A
ACS Nano; 2023 Jul; 17(14):13500-13509. PubMed ID: 37435892
[TBL] [Abstract][Full Text] [Related]
2. The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility.
Spliid CB; Toledo AG; Sanderson P; Mao Y; Gatto F; Gustavsson T; Choudhary S; Saldanha AL; Vogelsang RP; Gögenur I; Theander TG; Leach FE; Amster IJ; Esko JD; Salanti A; Clausen TM
J Biol Chem; 2021 Dec; 297(6):101391. PubMed ID: 34762909
[TBL] [Abstract][Full Text] [Related]
3. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.
Agerbaek MØ; Pereira MA; Clausen TM; Pehrson C; Oo HZ; Spliid C; Rich JR; Fung V; Nkrumah F; Neequaye J; Biggar RJ; Reynolds SJ; Tosato G; Pullarkat ST; Ayers LW; Theander TG; Daugaard M; Bhatia K; Nielsen MA; Mbulaiteye SM; Salanti A
Int J Cancer; 2017 Apr; 140(7):1597-1608. PubMed ID: 27997697
[TBL] [Abstract][Full Text] [Related]
4. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.
Khunrae P; Dahlbäck M; Nielsen MA; Andersen G; Ditlev SB; Resende M; Pinto VV; Theander TG; Higgins MK; Salanti A
J Mol Biol; 2010 Apr; 397(3):826-34. PubMed ID: 20109466
[TBL] [Abstract][Full Text] [Related]
5. Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.
Clausen TM; Pereira MA; Al Nakouzi N; Oo HZ; Agerbæk MØ; Lee S; Ørum-Madsen MS; Kristensen AR; El-Naggar A; Grandgenett PM; Grem JL; Hollingsworth MA; Holst PJ; Theander T; Sorensen PH; Daugaard M; Salanti A
Mol Cancer Res; 2016 Dec; 14(12):1288-1299. PubMed ID: 27655130
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.
Sugiura N; Clausen TM; Shioiri T; Gustavsson T; Watanabe H; Salanti A
Glycoconj J; 2016 Dec; 33(6):985-994. PubMed ID: 27287227
[TBL] [Abstract][Full Text] [Related]
7. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
[TBL] [Abstract][Full Text] [Related]
8. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
Elife; 2022 Feb; 11():. PubMed ID: 35103596
[TBL] [Abstract][Full Text] [Related]
9. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1.
Ayres Pereira M; Mandel Clausen T; Pehrson C; Mao Y; Resende M; Daugaard M; Riis Kristensen A; Spliid C; Mathiesen L; E Knudsen L; Damm P; G Theander T; R Hansson S; A Nielsen M; Salanti A
PLoS Pathog; 2016 Aug; 12(8):e1005831. PubMed ID: 27556547
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into chondroitin sulfate binding in pregnancy-associated malaria.
Khunrae P; Higgins MK
Biochem Soc Trans; 2010 Oct; 38(5):1337-41. PubMed ID: 20863310
[TBL] [Abstract][Full Text] [Related]
11. Development of a bispecific immune engager using a recombinant malaria protein.
Nordmaj MA; Roberts ME; Sachse ES; Dagil R; Andersen AP; Skeltved N; Grunddal KV; Erdoğan SM; Choudhary S; Gustsavsson T; Ørum-Madsen MS; Moskalev I; Tian W; Yang Z; Clausen TM; Theander TG; Daugaard M; Nielsen MA; Salanti A
Cell Death Dis; 2021 Apr; 12(4):353. PubMed ID: 33824272
[TBL] [Abstract][Full Text] [Related]
12. Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer.
Zhou M; Lai W; Li G; Wang F; Liu W; Liao J; Yang H; Liu Y; Zhang Q; Tang Q; Hu C; Huang J; Zhang R
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25635-25648. PubMed ID: 34038097
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.
Raghavan SSR; Dagil R; Lopez-Perez M; Conrad J; Bassi MR; Quintana MDP; Choudhary S; Gustavsson T; Wang Y; Gourdon P; Ofori MF; Christensen SB; Minja DTR; Schmiegelow C; Nielsen MA; Barfod L; Hviid L; Salanti A; Lavstsen T; Wang K
PLoS Pathog; 2022 Nov; 18(11):e1010924. PubMed ID: 36383559
[TBL] [Abstract][Full Text] [Related]
14. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
[TBL] [Abstract][Full Text] [Related]
15. Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.
Salanti A; Clausen TM; Agerbæk MØ; Al Nakouzi N; Dahlbäck M; Oo HZ; Lee S; Gustavsson T; Rich JR; Hedberg BJ; Mao Y; Barington L; Pereira MA; LoBello J; Endo M; Fazli L; Soden J; Wang CK; Sander AF; Dagil R; Thrane S; Holst PJ; Meng L; Favero F; Weiss GJ; Nielsen MA; Freeth J; Nielsen TO; Zaia J; Tran NL; Trent J; Babcook JS; Theander TG; Sorensen PH; Daugaard M
Cancer Cell; 2015 Oct; 28(4):500-514. PubMed ID: 26461094
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding.
Wang K; Dagil R; Lavstsen T; Misra SK; Spliid CB; Wang Y; Gustavsson T; Sandoval DR; Vidal-Calvo EE; Choudhary S; Agerbaek MØ; Lindorff-Larsen K; Nielsen MA; Theander TG; Sharp JS; Clausen TM; Gourdon P; Salanti A
Nat Commun; 2021 May; 12(1):2956. PubMed ID: 34011972
[TBL] [Abstract][Full Text] [Related]
18. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA.
Resende M; Nielsen MA; Dahlbäck M; Ditlev SB; Andersen P; Sander AF; Ndam NT; Theander TG; Salanti A
Malar J; 2008 Jun; 7():104. PubMed ID: 18534039
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of a ring-infected erythrocyte surface antigen (RESA)-like export protein gene in Plasmodium falciparum confers stable chondroitin 4-sulfate cytoadherence capacity.
Goel S; Muthusamy A; Miao J; Cui L; Salanti A; Winzeler EA; Gowda DC
J Biol Chem; 2014 Dec; 289(49):34408-21. PubMed ID: 25342752
[TBL] [Abstract][Full Text] [Related]
20. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
